OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling
James A. Roberts, Richard D. Rainbow, Parveen Sharma
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6723-6723
Open Access | Times Cited: 14

Showing 14 citing articles:

Matrine induces cardiotoxicity by promoting ferroptosis through the Nrf2 antioxidant system in H9c2 cells
Xi Wang, Zixiong Lin, Xinyi Tang, et al.
Toxicology Letters (2024) Vol. 397, pp. 11-22
Closed Access | Times Cited: 5

Dietary Supplements as Modulators of the Nrf2 Pathway to Enhance Intracellular Antioxidant Responses and Protect Against Dyslipidemia-Associated Cardiovascular Complications
Sinenhlanhla X. H. Mthembu, Sithandiwe E. Mazibuko-Mbeje, Sonia Silvestri, et al.
Food Reviews International (2025), pp. 1-29
Closed Access

Sex-Specific Association between <i>HO-1</i> (GT)n Promoter Polymorphism and Large-Artery Atherosclerosis Stroke
Jintao Li, Junting Chen, Jia Wen, et al.
Journal of Atherosclerosis and Thrombosis (2025)
Open Access

Angiotensin-converting enzyme inhibitors provide a protective effect on hypoxia-induced injury in human coronary artery endothelial cells via Nrf2 signaling and PLVAP
Qiubing Zhang, Fang Gou, Ping Shi, et al.
Clinical Hemorheology and Microcirculation (2024) Vol. 87, Iss. 2, pp. 141-170
Closed Access | Times Cited: 2

Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC
Fushi Han, Shuzhen Chen, Kangwei Zhang, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1

Synthetic antioxidant TS-13 reduces doxorubicin cardiotoxicity
E. B. Menshchikova, R. A. Knyazev, Н. В. Трифонова, et al.
Сибирский научный медицинский журнал (2023) Vol. 43, Iss. 5, pp. 108-117
Open Access | Times Cited: 2

NMNATs expression inhibition mediated NAD+ deficiency plays a critical role in doxorubicin-induced hepatotoxicity in mice
Fang Cheng, Yongtai Zhang, Hongli Xiong, et al.
Toxicology and Applied Pharmacology (2023) Vol. 482, pp. 116799-116799
Closed Access | Times Cited: 2

Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics
Ramin Raoufinia, Hamid Reza Rahimi, M Abbaszadeh, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 21, pp. 1667-1680
Closed Access

Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases
Qi Wu, Jiangting Yao, Mengyun Xiao, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 874-883
Closed Access

Synthetic Antioxidant TS-13 Reduces the Cardiotoxicity of Doxorubicin
E. B. Menshchikova, R. A. Knyazev, Н. В. Трифонова, et al.
Cell and Tissue Biology (2024) Vol. 18, Iss. 5, pp. 570-578
Closed Access

Redox Imbalance and Antioxidant Defenses Dysfunction: Key Contributors to Early Aging in Childhood Cancer Survivors
Vanessa Cossu, Nadia Bertola, Chiara Fresia, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1397-1397
Open Access

Page 1

Scroll to top